The FDA has granted emergency use authorization for the Aptima Zika virus assay system, from Hologic, for detection of the...
Luminex Corporation has received Emergency Use Authorization (EUA) from the FDA for a multiplex nucleic acid test called the xMAP...
Abbott announced that the U.S. FDA has authorised its molecular test, the Abbott RealTime ZIKA test, to detect Zika virus...
Grifols announced that the FDA approved the Procleix Zika Virus assay for the detection of the virus in individual or...
Background: Respiratory syncytial virus (RSV) is a leading cause of respiratory tract illness in young children and a major cause of hospital admissions globally.
Innovation Pharmaceuticals announced that brilacidin, the Company’s defensin-mimetic drug candidate exhibiting broad-spectrum antiviral properties, is to be evaluated for its treatment potential against the monkeypox virus.
The immunopathology of respiratory syncytial virus (RSV) infection varies considerably, severe disease occurring only in a minority of the affected children.
SARS-CoV-2 outbreak is the first pandemic of the century. SARS-CoV-2 infection is transmitted through droplets; other transmission routes are hypothesized but not confirmed.
This meta-analysis aims to present a collective view on the relationship between viral infection and IPF.
Hepatitis E virus (HEV) is a single-stranded positive-sense RNA virus. HEV can cause both acute and chronic hepatitis, with the latter usually occurring in immunocompromised patients. Modes of transmission range from the classic...